ACTA1 and cancer: Several studies have shown that the number of α-SMA-positive CAFs correlates with shorter overall survival in esophageal and pancreatic cancer patients [12,13], suggesting that depletion of α-SMA-positive cells can be a promising therapeutic strategy in cancer patients.